{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:32:56Z","timestamp":1793946776530,"version":"4.8.0"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Given that previous studies have provided mixed results on cathinone neurotoxicity, we compared the effects of \u2018functionally equivalent\u2019 dosing regimens of methamphetamine (METH), methcathinone, and \u03b1-pyrrolidinopropiophenone (\u03b1-PPP) on behavioral and neurochemical markers associated with dopaminergic alterations and cognitive function. Male Swiss Webster mice received METH (5\u2005mg\/kg), methcathinone (80\u2005mg\/kg), or \u03b1-PPP (80\u2005mg\/kg), using a \u2018binge\u2019-like dosing regimen (q2h \u00d7 4, intraperitoneal). Body weight and temperature were recorded during dosing. Behavior was assessed 2\u20134 days later, followed by brain extraction. Motor function was evaluated by open-field testing and stride length analysis. Cognitive function was assessed with the passive avoidance test. Striatal levels of dopamine and its major metabolites were measured using ultra-HPLC. All three drug treatments induced weight loss. METH treatment produced a small, transient increase in rectal temperature (~1 \u00b0C); methcathinone and \u03b1-PPP did not. All three drug treatments impaired passive avoidance performance (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u20050.05 to\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u20050.01), but none produced persistent motor deficits. METH and methcathinone treatment significantly reduced striatal dopamine levels (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u20050.001), whereas \u03b1-PPP did not, and only METH treatment increased homovanillic acid\/dopamine turnover (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u20050.01). Only METH exposure triggered measurable changes in dopamine metabolism and a small, transient increase in temperature, highlighting its distinct neurochemical profile compared with methcathinone and \u03b1-PPP under these conditions. All three drug treatments impaired passive avoidance performance, but none caused lasting motor deficits, demonstrating that behavioral deficits can occur without persistent motor changes.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/fbp.0000000000000899","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:00:10Z","timestamp":1787767210000},"page":"349-359","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Direct comparison of the effects of functionally equivalent dosing regimens of methamphetamine, methcathinone, and \u03b1-pyrrolidinopropiophenone on behavioral and neurochemical markers of stimulant-induced neurotoxicity"],"prefix":"10.1097","volume":"37","author":[{"given":"Neha M.","family":"Chitre","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences, Mercer University College of Pharmacy, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda M.","family":"Gannon","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Mercer University College of Pharmacy, Atlanta, Georgia"},{"name":"Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, Arkansas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce E.","family":"Blough","sequence":"additional","affiliation":[{"name":"Center for Drug Discovery, Research Triangle Institute, Research Triangle Park, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin S.","family":"Murnane","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Mercer University College of Pharmacy, Atlanta, Georgia"},{"name":"Department of Pharmacology, Toxicology & Neuroscience, School of Graduate Studies, Louisiana State University Health Sciences Center"},{"name":"Department of Psychiatry and Behavioral Medicine, School of Medicine, Louisiana State University Health Sciences Center"},{"name":"Louisiana Addiction Research Center, Louisiana State University Health Sciences Center, Shreveport, Louisiana, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,11,27]]},"reference":[{"key":"R1-20261106","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/S0022-3565(25)12160-5","article-title":"Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents.","volume":"275","author":"Albers","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"R2-20261106","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0006-8993(09)90007-5","article-title":"Low environmental temperatures or pharmacologic agents that produce hypothermia decrease methamphetamine neurotoxicity in mice.","volume":"658","author":"Ali","year":"1994","journal-title":"Brain Res"},{"key":"R3-20261106","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1124\/jpet.116.237768","article-title":"Dissecting the influence of two structural substituents on the differential neurotoxic effects of acute methamphetamine and mephedrone treatment on dopamine nerve endings with the use of 4-methylmethamphetamine and methcathinone.","volume":"360","author":"Anneken","year":"2017","journal-title":"J Pharmacol Exp Ther"},{"key":"R4-20261106","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/npp.2013.307","article-title":"Methamphetamine causes degeneration of dopamine cell bodies and terminals of the nigrostriatal pathway evidenced by silver staining.","volume":"39","author":"Ares-Santos","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"R5-20261106","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/add.12601","article-title":"Awash in a sea of \u2018bath salts\u2019: implications for biomedical research and public health.","volume":"109","author":"Baumann","year":"2014","journal-title":"Addiction"},{"key":"R6-20261106","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/npp.2011.304","article-title":"The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue.","volume":"37","author":"Baumann","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"R7-20261106","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.psyneuen.2010.12.007","article-title":"Sex differences in methamphetamine toxicity in mice: effect on brain dopamine signaling pathways.","volume":"36","author":"Bourque","year":"2011","journal-title":"Psychoneuroendocrinology"},{"key":"R8-20261106","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4161\/23328940.2014.982049","article-title":"Amphetamine- and methamphetamine-induced hyperthermia: Implications of the effects produced in brain vasculature and peripheral organs to forebrain neurotoxicity.","volume":"1","author":"Bowyer","year":"2014","journal-title":"Temperature (Austin)"},{"key":"R9-20261106","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/S0022-3565(25)38650-7","article-title":"Further studies of the role of hyperthermia in methamphetamine neurotoxicity.","volume":"268","author":"Bowyer","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"R10-20261106","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/syn.20130","article-title":"Interactions of dopamine D1 and D2 receptor antagonists with D-methamphetamine-induced hyperthermia and striatal dopamine and serotonin reductions.","volume":"56","author":"Broening","year":"2005","journal-title":"Synapse"},{"key":"R11-20261106","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1037\/0735-7044.121.4.732","article-title":"Different temporal profiles of amnesia after intra-hippocampus and intra-amygdala infusions of anisomycin.","volume":"121","author":"Canal","year":"2007","journal-title":"Behav Neurosci"},{"key":"R12-20261106","doi-asserted-by":"crossref","first-page":"112413","DOI":"10.1016\/j.bbr.2019.112413","article-title":"The acute toxic and neurotoxic effects of 3,4-methylenedioxymethamphetamine are more pronounced in adolescent than adult mice.","volume":"380","author":"Chitre","year":"2020","journal-title":"Behav Brain Res"},{"key":"R13-20261106","doi-asserted-by":"crossref","first-page":"107976","DOI":"10.1016\/j.neuropharm.2020.107976","article-title":"Docosahexaenoic acid protects motor function and increases dopamine synthesis in a rat model of Parkinson\u2019s disease via mechanisms associated with increased protein kinase activity in the striatum.","volume":"167","author":"Chitre","year":"2020","journal-title":"Neuropharmacology"},{"key":"R14-20261106","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.drugalcdep.2014.10.027","article-title":"Methamphetamine\/amphetamine abuse and risk of Parkinson\u2019s disease in Utah: a population-based assessment.","volume":"146","author":"Curtin","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"R15-20261106","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0166-4328(01)00211-X","article-title":"Memory disruption in rats with nigral lesions induced by MPTP: a model for early Parkinson\u2019s disease amnesia.","volume":"124","author":"Da Cunha","year":"2001","journal-title":"Behav Brain Res"},{"key":"R16-20261106","doi-asserted-by":"crossref","first-page":"6230","DOI":"10.3390\/ijms24076230","article-title":"Synthetic cathinones and neurotoxicity risks: a systematic review.","volume":"24","author":"Daziani","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R17-20261106","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1006\/exnr.2002.7891","article-title":"Modeling Parkinson\u2019s disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway.","volume":"175","author":"Deumens","year":"2002","journal-title":"Exp Neurol"},{"key":"R18-20261106","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2174\/157015911795017399","article-title":"Markers associated with sex differences in methamphetamine-induced striatal dopamine neurotoxicity.","volume":"9","author":"Dluzen","year":"2011","journal-title":"Curr Neuropharmacol"},{"key":"R20-20261106","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.bcp.2013.04.004","article-title":"Substituted methcathinones differ in transporter and receptor interactions.","volume":"85","author":"Eshleman","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"R21-20261106","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1124\/jpet.116.236349","article-title":"Structure-activity relationships of substituted cathinones, with transporter binding, uptake, and release.","volume":"360","author":"Eshleman","year":"2017","journal-title":"J Pharmacol Exp Ther"},{"key":"R22-20261106","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/npp.2012.233","article-title":"In vivo effects of abused \u2018bath salt\u2019 constituent 3,4-methylenedioxypyrovalerone (MDPV) in mice: drug discrimination, thermoregulation, and locomotor activity.","volume":"38","author":"Fantegrossi","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"R23-20261106","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0165-0270(01)00485-X","article-title":"A simple method to measure stride length as an index of nigrostriatal dysfunction in mice.","volume":"113","author":"Fernagut","year":"2002","journal-title":"J Neurosci Methods"},{"key":"R24-20261106","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1146\/annurev.pharmtox.47.120505.105140","article-title":"New insights into the mechanism of action of amphetamines.","volume":"47","author":"Fleckenstein","year":"2007","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"R25-20261106","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1124\/jpet.116.239376","article-title":"Individual differences in the relative reinforcing effects of 3,4-methylenedioxypyrovalerone under fixed and progressive ratio schedules of reinforcement in rats.","volume":"361","author":"Gannon","year":"2017","journal-title":"J Pharmacol Exp Ther"},{"key":"R26-20261106","first-page":"19","article-title":"Biochemical pathophysiology of Parkinson\u2019s disease.","volume":"45","author":"Hornykiewicz","year":"1987","journal-title":"Adv Neurol"},{"key":"R27-20261106","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/FBP.0000000000000492","article-title":"Repeated administration of synthetic cathinone 3,4-methylenedioxypyrovalerone persistently increases impulsive choice in rats.","volume":"30","author":"Hyatt","year":"2019","journal-title":"Behav Pharmacol"},{"key":"R28-20261106","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/FBP.0000000000000548","article-title":"The synthetic cathinone 3,4-methylenedioxypyrovalerone increases impulsive action in rats.","volume":"31","author":"Hyatt","year":"2020","journal-title":"Behav Pharmacol"},{"key":"R29-20261106","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00213-018-5067-5","article-title":"Cognitive deficits and neurotoxicity induced by synthetic cathinones: is there a role for neuroinflammation?","volume":"236","author":"Leyrer-Jackson","year":"2019","journal-title":"Psychopharmacology (Berl)"},{"key":"R30-20261106","doi-asserted-by":"crossref","first-page":"108570","DOI":"10.1016\/j.neuropharm.2021.108570","article-title":"\u03b1-PPP and its derivatives are selective partial releasers at the human norepinephrine transporter: a pharmacological characterization of interactions between pyrrolidinopropiophenones and high and low affinity monoamine transporters.","volume":"190","author":"Maier","year":"2021","journal-title":"Neuropharmacology"},{"key":"R31-20261106","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neuro.2015.08.006","article-title":"Characterization of binge-dosed methamphetamine-induced neurotoxicity and neuroinflammation.","volume":"50","author":"McConnell","year":"2015","journal-title":"Neurotoxicology"},{"key":"R32-20261106","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF02740694","article-title":"The role of temperature, stress, and other factors in the neurotoxicity of the substituted amphetamines 3,4-methylenedioxymethamphetamine and fenfluramine.","volume":"11","author":"Miller","year":"1995","journal-title":"Mol Neurobiol"},{"key":"R33-20261106","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.drugalcdep.2012.07.003","article-title":"Changes in ambient temperature differentially alter the thermoregulatory, cardiac and locomotor stimulant effects of 4-methylmethcathinone (mephedrone).","volume":"127","author":"Miller","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"R34-20261106","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/brain\/awh046","article-title":"Why is parkinsonism not a feature of human methamphetamine users?","volume":"127","author":"Moszczynska","year":"2004","journal-title":"Brain"},{"key":"R35-20261106","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00213-011-2504-0","article-title":"Effects of exposure to amphetamine derivatives on passive avoidance performance and the central levels of monoamines and their metabolites in mice: correlations between behavior and neurochemistry.","volume":"220","author":"Murnane","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"key":"R37-20261106","doi-asserted-by":"crossref","first-page":"e3000410","DOI":"10.1371\/journal.pbio.3000410","article-title":"The ARRIVE guidelines 2.0: updated guidelines for reporting animal research.","volume":"18","author":"Percie du Sert","year":"2020","journal-title":"PLoS Biol"},{"key":"R38-20261106","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s13181-011-0193-z","article-title":"The toxicology of bath salts: a review of synthetic cathinones.","volume":"8","author":"Prosser","year":"2012","journal-title":"J Med Toxicol"},{"key":"R39-20261106","first-page":"479","article-title":"Cage change influences serum corticosterone and anxiety-like behaviors in the mouse.","volume":"50","author":"Rasmussen","year":"2011","journal-title":"J Am Assoc Lab Anim Sci"},{"key":"R40-20261106","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s00213-018-5044-z","article-title":"Effects of the second-generation \u2018bath salt\u2019 cathinone alpha-pyrrolidinopropiophenone (\u03b1-PPP) on behavior and monoamine neurochemistry in male mice.","volume":"236","author":"Ray","year":"2019","journal-title":"Psychopharmacology (Berl)"},{"key":"R41-20261106","doi-asserted-by":"crossref","first-page":"272","DOI":"10.30802\/AALAS-JAALAS-20-000093","article-title":"Effects of laboratory housing conditions on core temperature and locomotor activity in mice.","volume":"60","author":"Russell","year":"2021","journal-title":"J Am Assoc Lab Anim Sci"},{"key":"R42-20261106","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.neuron.2011.02.010","article-title":"How addictive drugs disrupt presynaptic dopamine neurotransmission.","volume":"69","author":"Sulzer","year":"2011","journal-title":"Neuron"},{"key":"R44-20261106","doi-asserted-by":"crossref","first-page":"1526270","DOI":"10.3389\/fphar.2025.1526270","article-title":"Neurotoxicity mechanisms and clinical implications of six common recreational drugs.","volume":"16","author":"Wang","year":"2025","journal-title":"Front Pharmacol"},{"key":"R43-20261106","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/1471-2202-13-142","article-title":"Quantitative assessment of gait and neurochemical correlation in a classical murine model of Parkinson\u2019s disease.","volume":"13","author":"Wang","year":"2012","journal-title":"BMC Neurosci"},{"key":"R45-20261106","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3390\/ph13070155","article-title":"Substance use disorder in the COVID-19 pandemic: a systematic review of vulnerabilities and complications.","volume":"13","author":"Wei","year":"2020","journal-title":"Pharmaceuticals (Basel)"},{"issue":"149","key":"R46-20261106","first-page":"e59878","article-title":"Low-cost gait analysis for behavioral phenotyping of mouse models of neuromuscular disease.","author":"Wertman","year":"2019","journal-title":"J Vis Exp"},{"key":"R47-20261106","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1006\/nlme.2001.4008","article-title":"Multiple parallel memory systems in the brain of the rat.","volume":"77","author":"White","year":"2002","journal-title":"Neurobiol Learn Mem"},{"key":"R48-20261106","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0166-4328(02)00402-3","article-title":"Mnemonic functions of dorsal striatum and hippocampus in aversive conditioning.","volume":"142","author":"White","year":"2003","journal-title":"Behav Brain Res"},{"key":"R49-20261106","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF03159728","article-title":"Compensatory responses to nigrostriatal bundle injury. Studies with 6-hydroxydopamine in an animal model of parkinsonism.","volume":"10","author":"Zigmond","year":"1989","journal-title":"Mol Chem Neuropathol"}],"container-title":["Behavioural Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/FBP.0000000000000899","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:01:20Z","timestamp":1793944880000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/FBP.0000000000000899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11,27]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/fbp.0000000000000899","relation":{},"ISSN":["0955-8810","1473-5849"],"issn-type":[{"value":"0955-8810","type":"print"},{"value":"1473-5849","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,11,27]]},"assertion":[{"value":"2026-03-20","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}